Return to Article Details
THE ROLE OF SEVERAL ¹⁸F-FDG PET/CT METABOLIC PARAMETERS IN PREDICTING TREATMENT RESPONSE FOLLOWING CONCURRENT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III ESOPHAGEAL CANCER
Download
Download PDF